Professional Documents
Culture Documents
Normal pregnancy
physiology
Increased Decreased
intravascular Hypercoagulability systemic vascular
volume resistance
Pulmonary
hypertension
High
maternal
mortality
risk.
Severe Marfan
cardiomiopathy syndrome
BACKGROUND
WOMEN WITH CARDIAC DISEASE IN PREGNANCY ARE AT HIGHER RISK FOR:
Cardiovascular Neonatal
Maternal death
complication complication
BACKGROUND
Trial of intervention
specifics for
cardiac disease in
pregnancy.
Fatigue
Limitation of
Cyanosis physical
ability
Dyspnea on Symptomps
Palpitations
exertion and signs
Shortness of
breath
EPIDEMIOLOGY
Complicate 1-4% of pregnancies.
10-25% of Genetics:
maternal
mortality. Maternal congenital heart defect>>>increased
risk for the fetus to get congenital heart defect
ETIOLOGY
Increase in
cardiac Incerease in
output intravascula
during r volume
parturition
Etiology
Postpartum
increase in
Hypercoagu
intravascula
lability
r volume
load
CLASSIFICATION
Complication
Maternal Neonatal
mortality complication
Decreased systemic
Maternal mortality
vascular resistance
Incerease in intravascular
volume
Postpartum increase in
intravascular volume load
Hypercoagulability
Misscariage
Growth
restriction
Preconception
counseling
Management
Prenatal
General
care/antepartum
management
testing
GENERAL MANAGEMENT
Antepartum activity restriction
WORKUP:
THYROID FUNCTION
RULING OUT: DRUGS, ALCOHOL, CAFFEINE, SMOKING
ECG
USUALLY BENIGN
COARTATION OF AORTA
AVOID
ARRHYTMIA
BRADYCARDIA
MYOCARDIAL DEPPRESSANT
MARFAN SYNDROME
STRESS ANGIOPLASTY
THROMBOLYTIC THERAPHY